These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4348855)

  • 1. Angiotensin antagonism and antihypertensive activity of phosphodiesterase inhibiting agents.
    Pettinger W; Sheppard H; Palkoski Z; Renyi E
    Life Sci I; 1973 Jan; 12(2):49-62. PubMed ID: 4348855
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of hydralazine and dihydralazine, as well as other blood pressure-lowering drugs on water uptake and excretion in rats].
    Peskar B; Leodolter S; Hertting G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):292-3. PubMed ID: 4242434
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of various blood pressure-lowering drugs on water uptake and output in rats].
    Peskar B; Leodolter S; Hertting G
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 265(4):335-46. PubMed ID: 4244610
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship of the renal vascular activity of angiotensin II to the autonomic nervous system.
    McGiff JC; Fasy TM
    J Clin Invest; 1965 Nov; 44(11):1911-23. PubMed ID: 4284771
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in the hypertensive effects of angiotensin by adrenergic and anti-adrenergic agents].
    Schmitt H; Schmitt H
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):31-46. PubMed ID: 4296394
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of the hypotensive action of prazosin.
    Oates HF; Graham RM; Stokes GS
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):41-8. PubMed ID: 901072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanisms of action of some antihypertensive drugs.
    Laverty R
    Br Med Bull; 1973 May; 29(2):152-7. PubMed ID: 4356551
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin blocking actions of guancydine.
    Cummings JR; Welter AN; Grace JL; Gray WD
    J Pharmacol Exp Ther; 1969 Dec; 170(2):334-46. PubMed ID: 4311323
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of the hypertensive effect of metaraminol.
    Stojanova D; Glavaś E; Trajkov T; Nikodijevic B
    Experientia; 1964 Dec; 20(12):698-9. PubMed ID: 5858605
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of bretylium and guanethidine on the relaxations of the rat isolated fundal strip preparation, evoked by indirect stimulation.
    Gaitondé BB; Nimbkar AY
    Br J Pharmacol; 1973 Feb; 47(2):268-71. PubMed ID: 4722042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of bretylium on the cardiovascular response to tyramine in the rat.
    Clarke DE
    Arch Int Pharmacodyn Ther; 1969 Nov; 182(1):78-97. PubMed ID: 4391498
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamic spectrum of vasopressor and vasodilator drugs.
    Lewis CM; Weil MH
    JAMA; 1969 May; 208(8):1391-8. PubMed ID: 4307223
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification by guanethidine and nethalide of the pressor effects of bradykinin in the rat.
    Miele E; De Natale G
    Arch Int Pharmacodyn Ther; 1966 Nov; 164(1):56-66. PubMed ID: 4382037
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of bretylium and guanethidine on the pressor response to 5-hydroxytryptamine in rats.
    Trajkov T; Glavas E; Stojanova D; Nikodijević B
    Arch Int Pharmacodyn Ther; 1965 Jul; 156(1):59-65. PubMed ID: 5858840
    [No Abstract]   [Full Text] [Related]  

  • 15. Some factors affecting the neuron blocking action of guanethidine, xylocholine, bretylium and debrisoquin.
    Prasad CM; Shah DS; Gulati OD
    Jpn J Pharmacol; 1973 Dec; 23(6):805-11. PubMed ID: 4544694
    [No Abstract]   [Full Text] [Related]  

  • 16. The central action of clonidine and its antagonism.
    Katic F; Lavery H; Lowe RD
    Br J Pharmacol; 1972 Apr; 44(4):779-87. PubMed ID: 4339388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of sympathetic vasodilator responses during renal nerve stimulation.
    Gomer SK; Zimmerman BG
    J Pharmacol Exp Ther; 1972 Apr; 181(1):75-82. PubMed ID: 4401178
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentiation by [4,4'-biphenylenebis(2-oxoethylene)]bis-[2,2-diethoxyethyl) dimethylammonium bromide] (DMAE) of the sympathetic component of the vasopressor response to angiotensin.
    Greenberg S; Long JP
    J Pharmacol Exp Ther; 1970 Jul; 174(1):35-44. PubMed ID: 4316535
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of hypotensive drugs on plasma renin activity in the rat].
    Meyer DK; Peskar B; Tauchmann U; Hertting G
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):403-4. PubMed ID: 4253830
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological analysis of synaptically mediated increase in cyclic adenosine monophosphate in rabbit superior cervical ganglion.
    Kalix P; McAfee DA; Schorderet M; Greengard P
    J Pharmacol Exp Ther; 1974 Mar; 188(3):676-87. PubMed ID: 4361252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.